Table 2.
Presentation and demographics of WUV/KIPyV infected study subjects
| Respiratory disease | Total [WU/KI] | Mean age (range) | M/F | Immunosuppressed | Co-detected viruses |
|---|---|---|---|---|---|
| LRTI | 8 [5/3]/114 | 1 (0.3–1.5) | 5/3 | 0/8 | RSV (n = 2), AdV (n = 3), HBoV (n = 1) |
| URTI | 5 [2/3]/75 | 14 (0.7–34) | 4/1 | 3/5a | AdV (n = 2), HBoV (n = 1) |
| None | 6 [3/3]/56 | 5 (1.5–15) | 4/2 | 5/6b | AdV (n = 1), B19 (n = 1) |
a
The three immunosuppressed study subjects had acute lymphoblastic leukaemia (ALL), bone marrow transplant, and neutropoenic; none showed virus co-infections.
b
Three with ALL, one with Gaucher's disease, one immunosuppressed for unspecified reasons, one showed B19 co-infection.